168 related articles for article (PubMed ID: 10683488)
1. Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3-b]indol- 3(3H)-ones in mice.
De Sarro G; Carotti A; Campagna F; Mckernan R; Rizzo M; Falconi U; Palluotto F; Giusti P; Rettore C; De Sarro A
Pharmacol Biochem Behav; 2000 Mar; 65(3):475-87. PubMed ID: 10683488
[TBL] [Abstract][Full Text] [Related]
2. Azirino[1, 2-d][1, 4]benzodiazepine derivatives and related 1,4-benzodiazepines as anticonvulsant agents in DBA/2 mice.
De Sarro G; Chimirri A; Zappala M; Guisti P; Lipartiti M; De Sarro A
Gen Pharmacol; 1996 Oct; 27(7):1155-62. PubMed ID: 8981061
[TBL] [Abstract][Full Text] [Related]
3. Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice.
De Sarro G; Chimirri A; McKernan R; Quirk K; Giusti P; De Sarro A
Pharmacol Biochem Behav; 1997 Sep; 58(1):281-9. PubMed ID: 9264104
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of 2-aryl-2,5-dihydropyridazino [4,3-b]indol-3(3H)-ones at the benzodiazepine receptor.
Palluotto F; Carotti A; Casini G; Campagna F; Genchi G; Rizzo M; De Sarro GB
Bioorg Med Chem; 1996 Dec; 4(12):2091-104. PubMed ID: 9022974
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.
Jackson HC; Hansen HC; Kristiansen M; Suzdak PD; Klitgaard H; Judge ME; Swedberg MD
Eur J Pharmacol; 1996 Jul; 308(1):21-30. PubMed ID: 8836628
[TBL] [Abstract][Full Text] [Related]
6. 2-Aryl-2,5-dihydropyridazino[4,3-b]indol-3(3H)-ones: novel rigid planar benzodiazepine receptor ligands.
Campagna F; Carotti A; Casini G; Palluotto F; Genchi G; De Sarro GB
Bioorg Med Chem; 1993 Dec; 1(6):437-46. PubMed ID: 8087565
[TBL] [Abstract][Full Text] [Related]
7. Behavioural and convulsant actions of two methyl esters of beta-carboline-3-carboxylic acid in photosensitive baboons and in DBA/2 mice.
Croucher M; De Sarro G; Jensen L; Meldrum B
Eur J Pharmacol; 1984 Sep; 104(1-2):55-60. PubMed ID: 6499918
[TBL] [Abstract][Full Text] [Related]
8. GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
de Sarro G; Chimirri A; De Sarro A; Gitto R; Grasso S; Giusti P; Chapman AG
Eur J Pharmacol; 1995 Dec; 294(2-3):411-22. PubMed ID: 8750701
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
Turski L; Stephens DN; Jensen LH; Petersen EN; Meldrum BS; Patel S; Hansen JB; Löscher W; Schneider HH; Schmiechen R
J Pharmacol Exp Ther; 1990 Apr; 253(1):344-52. PubMed ID: 1970362
[TBL] [Abstract][Full Text] [Related]
10. Relative anticonvulsant effects of GABAmimetic and GABA modulatory agents.
Holland KD; McKeon AC; Canney DJ; Covey DF; Ferrendelli JA
Epilepsia; 1992; 33(6):981-6. PubMed ID: 1334454
[TBL] [Abstract][Full Text] [Related]
11. 1,4-Benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice.
De Sarro G; Gitto R; Rizzo M; Zappia M; De Sarro A
Gen Pharmacol; 1996 Sep; 27(6):935-41. PubMed ID: 8909973
[TBL] [Abstract][Full Text] [Related]
12. Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines.
DeSarro GB; Zappalà M; Grasso S; Chimirri A; DeSarro A
Gen Pharmacol; 1993 Jul; 24(4):877-84. PubMed ID: 8224743
[TBL] [Abstract][Full Text] [Related]
13. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Sarma PV; Bokonjić DR
Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Pharmacol Biochem Behav; 2004 Oct; 79(2):279-90. PubMed ID: 15501303
[TBL] [Abstract][Full Text] [Related]
15. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists.
Jensen LH; Petersen EN; Braestrup C
Life Sci; 1983 Jul; 33(4):393-9. PubMed ID: 6308372
[TBL] [Abstract][Full Text] [Related]
16. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
17. Bidirectional effects of beta-carbolines in reflex epilepsy.
Chapman AG; De Sarro GB; Premachandra M; Meldrum BS
Brain Res Bull; 1987 Sep; 19(3):337-46. PubMed ID: 3119161
[TBL] [Abstract][Full Text] [Related]
18. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.
Löscher W; Hönack D; Scherkl R; Hashem A; Frey HH
J Pharmacol Exp Ther; 1990 Nov; 255(2):541-8. PubMed ID: 1978730
[TBL] [Abstract][Full Text] [Related]
20. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]